View Single Post
Old 01-09-2026, 11:10 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,870
Targeting IDO1 for cancer: Novel degraders show promise in preclinical studies

Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms.

More...
News is offline   Reply With Quote